Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Aikou Okamoto
Institution:
Jikei University School of Medicine
Observed institutions:
Jikei University School of Medicine,
National Cancer Centre Japan,
National Cancer Center Hospital,
National Cancer Center Research Institute
ORCID:
0000-0002-5079-0464
Observed ORCID:
0000-0002-5079-0464
OpenAlex ID:
A5061279097
Allelic imbalance and mutations of the PTEN gene in ovarian cancer
2000
·
Misato Saito
, Aikou Okamoto
, et al.
·
International Journal of Cancer
·
95
Allelic imbalance in chromosome band 18q21 andSMAD4 mutations in ovarian cancers
1999
·
Satoshi Takakura
, Aikou Okamoto
, et al.
·
Genes Chromosomes and Cancer
·
36
Relation between Nucleolar Size and Growth Characteristics in Small Cell Lung Cancer Cell Lines
1991
·
Takeo Matsumoto
, Takeo Terasaki
, et al.
·
Japanese Journal of Cancer Research
·
15
PDF
PARP inhibitors elicit a cellular senescence mediated inflammatory response in homologous recombination proficient cancer cells
2025
·
Misato Kamii
, Ryo Kamata
, et al.
·
Scientific Reports
·
13
PDF
Amyloid β Enhances Migration of Endothelial Progenitor Cells by Upregulating CX3CR1 in Response to Fractalkine, Which May Be Associated With Development of Choroidal Neovascularization
2011
·
Jiying Wang
, Kyoko Ohno-Matsui
, et al.
·
Arteriosclerosis Thrombosis and Vascular Biology
·
13
Y-box binding protein 1/cyclin A1 axis specifically promotes cell cycle progression at G2/M phase in ovarian cancer
2024
·
Yuichi Murakami
, Daisuke Katsuchi
, et al.
·
Scientific Reports
·
8
PDF
GLOBAL PHASE II STUDY OF RISOVALISIB, A SELECTIVE PI3Kα INHIBITOR, AS MONOTHERAPY IN PATIENTS WITH RECURRENT/PERSISTENT OVARIAN CLEAR CELL CARCINOMA HARBORING PIK3CA HOTSPOT MUTATIONS
2025
·
Xiaohua Wu
, Kan Yonemori
, et al.
·
International Journal of Gynecological Cancer
·
6
A randomized phase II study of secondary cytoreductive surgery in patients with relapsed ovarian cancer who have progressed on a PARP inhibitor as first-line maintenance therapy: the SOCCER-P study (KGOG 3067/JGOG 3036/APGOT-OV11)
2024
·
Hyun-Woong Cho
, Hee-Seung Kim
, et al.
·
International Journal of Gynecological Cancer
·
5
Heterogeneous treatment effect of dose‐dense paclitaxel plus carboplatin therapy for advanced ovarian cancer
2024
·
Ayumi Taguchi
, Kosuke Kato
, et al.
·
International Journal of Cancer
·
5
Neoadjuvant chemotherapy with interval debulking surgery in elderly women with advanced ovarian, fallopian tube, or primary peritoneal cancer: real-world evidence from japan
2026
·
Hiroko Machida
, Kei Kawana
, et al.
·
International Journal of Gynecological Cancer
·
1
Workforce and institutional factors associated with comprehensive genomic profiling utilization in gynecologic oncology: a nationwide questionnaire survey in Japan
2026
·
Tamotsu Sudo
, Kenta Masuda
, et al.
·
International Journal of Clinical Oncology
PDF
Long-term chemotherapy-induced peripheral neuropathy evaluated using patient-reported outcomes in gynecologic malignancies
2026
·
Chikage Narui
, Hiroshi Tanabe
, et al.
·
Journal of Gynecologic Oncology
PDF
In-utero cell transplantation for hypophosphatasia with gene-edited hESC-derived MSCs in a murine model
2026
·
Naoya Kitamura
, Akihiro Hasegawa
, et al.
·
Molecular Therapy Advances
Survival of vulvar squamous cell carcinoma vs. vulvar malignant melanoma:A nationwide cohort study in japan
2026
·
Shin Nishiio
, Sayako Nakagawa
, et al.
·
International Journal of Gynecological Cancer
Treatment patterns and clinical outcome in advanced/recurrent endometrial cancer after adjuvant chemotherapy: interim analysis of the JGOG2055s/PEACH study
2026
·
Yosuke Okui
, Yoshihito Yokoyama
, et al.
·
International Journal of Gynecological Cancer
Therapeutic effect of dose-dense paclitaxel plus carboplatin with or without bevacizumab for Japanese patients with epithelial ovarian cancer
2024
·
Yuki Kochi
, Satoshi Hosoya
, et al.
·
International Journal of Clinical Oncology
Show more works
View as search
Works count:
16
Citation count:
197
H-index:
6
I10-index:
5
Year
Topic
Type